Iniparib (BSI-201)

Shipping calculated at checkout.

Iniparib (BSI-201) is a PARP1 inhibitor with demonstrated effectiveness in triple-negative breast cancer (TNBC). Phase 3.

We Also Recommend

MOWIOL-DABCO (Mounting Medium) - 10x1ml

Parafilm® 50mm x 75m

Phase contrast 5 position (BF, DF, PH1, PH2, PH3)

Cyanide Standard, 1000ppm (1mL = 1mg CN?)

Sodium Deoxycholate (10%) Solution - 50ml